Liver transplantation meets gastrointestinal cancer.
Z Gastroenterol
; 62(1): 62-72, 2024 Jan.
Article
em En
| MEDLINE
| ID: mdl-38195110
ABSTRACT
Liver transplantation (LT) has emerged as a standard of care for patients with end-stage liver disease, providing a life-saving intervention for patients with severely compromised liver function in both the acute and chronic setting. While LT has also become a routine procedure for early-stage hepatocellular carcinoma (HCC), offering a potential cure by treating both the tumor and the underlying liver disease, its relevance in the context of other malignancies such as cholangiocellular carcinoma (CCA), combined hepatocellular-cholangiocarcinoma (cHCC-CCA) or liver metastases is still the subject of intense debate and no definite recommendations have yet been established. This review summarizes the current therapeutic standards in the context of LT for gastrointestinal malignancies and provides a reflection and outlook on current scientific and clinical developments.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias dos Ductos Biliares
/
Transplante de Fígado
/
Colangiocarcinoma
/
Carcinoma Hepatocelular
/
Neoplasias Gastrointestinais
/
Neoplasias Hepáticas
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Z Gastroenterol
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Alemanha